Professor Bart De Strooper (UK Dementia Research Institute at UCL) has been awarded an honorary CBE for his services to ...

Science minister Sir Patrick Vallance said he was "super excited" by advancements in dementia diagnosis and treatment ...

Patients in Wales could be some of the first to benefit new research looking at how Artificial Intelligence combined with ...

Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and lecanemab, were rejected by the Scottish Medicines Consortium (SMC), ...

Alzheimer’s Research UK said the new study “adds to the growing evidence that repairing the blood-brain barrier (BBB) itself could offer a new way to treat Alzheimer’s,” but added that it is too early ...

From blood tests to AI, new ways to diagnose dementia sooner and treat it faster set to be unlocked by new research challenge. From blood tests to ...

Omega fatty acids may help protect women from Alzheimer’s disease, revealing why more women are diagnosed, according to a study from King’s College London and Queen Mary University of London. The ...

University College London has published a study, part funded by Alzheimer’s Society’s Heather Corrie Impact Fund, which shows ...

Regulatory authorities in the UK are being urged to speed their review of lecanemab (Leqembi, Eisai) after the US Food and Drug Administration (FDA) approved it for early-stage Alzheimer's disease.

A new MoU fosters collaboration between leading institutes to explore diabetes' impact on brain health and cognitive decline.